Something has shifted in how people talk about their skincare routines, quietly enough that the industry almost missed it.
The language changed first: "skip-care", "skin fasting", "ingredient fatigue". Where beauty content once celebrated elaborate multi-step regimens as markers of commitment, a growing share of the same audience began treating simplicity as the more sophisticated position. Fewer products. Fewer steps. Fewer decisions. A deliberate reduction.
The data followed. Market trackers project strong growth for clean and minimalist beauty over the next decade, while consumer surveys consistently suggest that a meaningful share of buyers now scrutinise ingredient lists before purchasing.
The brief is not fewer ingredients. It is fewer unjustified ingredients.
When consumers simplify their routines, they are not making a statement about chemistry. They are making a statement about trust. They are removing products they cannot explain, not products they understand. The discipline is not subtraction for its own sake; it is the removal of whatever cannot justify its presence.
That is a fundamentally different brief than it first appears.
A formulator who reads "the market wants simplicity" and responds by cutting actives, reducing ingredient counts arbitrarily, or selecting raw materials primarily because they carry short names is misreading the signal. Consumers are not asking for less performance. They are asking for more legibility. Every ingredient should be present for a reason that, in principle, they could understand.
This distinction has direct consequences for oil-phase design. A phase assembled from six or seven components, each added at a different point in a formula's development history, some for sensorial reasons, some for stability, some inherited from a prior iteration, is not automatically more capable than a three-component system. It may simply be more opaque. And in today's market, opacity carries a cost that extends beyond the label.
Designing an oil phase for a skinimalist brief is not easier than designing a complex one. In several respects, it is harder.
When the number of components is reduced, the contribution of each one must be considered more deliberately. Choosing a single emollient that delivers both spread behaviour and afterfeel, without requiring correction from a secondary ingredient, demands greater technical specificity upfront.
In a minimalist brief, the antioxidant system should not be an afterthought added at the end of development; it should be designed into the phase from the beginning, because there is little room to compensate later. The co-emollient that shapes the finish cannot merely approximate the target; it must meet it, because there is no adjacent ingredient to adjust with.
This is the technical meaning of precision per ingredient: not fewer choices made quickly, but fewer choices made with greater care.
A practical way to test it early is simple: settling behaviour, friction evolution, and layering tolerance.
There is also an organoleptic dimension that is often underestimated. Simpler oil phases have fewer masking variables. When an emollient is slightly off, when the spreading profile drifts, when oxidative degradation begins to alter odour, there is nothing else in the phase to absorb the deviation. The formulator who works with a well-characterised, pre-stabilised lipid system begins from a known baseline. The one who assembles the phase from scratch absorbs the uncertainty of each component individually. Complexity does not guarantee performance; it often only postpones clarity.
The brands navigating routine fatigue most successfully are not those that have merely reduced their product count. They are those that have built genuine confidence in what remains. Curation is not the strategy; the justifiability of what is kept is the strategy.
For a formulator operating in that environment, the question is not "how many ingredients can I remove?" It is "can I defend every ingredient that stays?" And defence, in the context of a skinimalist brief, means sensorial precision, documented stability, traceable origin, and a function that is legible, not only internally, but also to the brand team that must translate it into a coherent story.
A lipid platform that arrives with a pre-defined sensorial direction, an antioxidant system integrated rather than added as a separate line item, and a clear origin narrative does not merely simplify the INCI. It simplifies the decision architecture behind it.
ESSENTIKA — SQA follows that logic: an olive-derived squalane base, a tocopherol system built into the blend from the start, and one co-emollient selected to steer sensorial direction with specificity. The short INCI is a result, not a premise, the outcome of upstream decisions so the formulator does not have to make them under pressure.
Skinimalism is not a brief for less formulation. It is a brief for formulation that can explain itself.
Ingredient partners who can answer that brief with documented precision, not only with a data sheet but with a coherent technical rationale, are the ones most likely to build durable positions in a market that is increasingly unimpressed by complexity for its own sake.
